Jump Financial »

Tourmaline Bio shares owned by Jump Financial

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-06-30 $357k 28k 12.86
2023-12-31 $380k 15k 26.18

More positions owned by Jump Financial

SPDR Dow Jones Industrial Average ETF Trust Etf (DIA)
Invesco QQQ Trust Series 1 Etf (QQQ)
POSCO Holdings Depositary Receipt (PKX)
Vanguard S&P 500 ETF Etf (VOO)
VanEck Semiconductor ETF Etf (SMH)
CME Group Common Stock (CME)
iShares 20 Year Treasury Bond ETF Etf (TLT)
Tesla Common Stock (TSLA)
Intercontinental Exchange Common Stock (ICE)
Technology Select Sector SPDR Fund Etf (XLK)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Netflix Common Stock (NFLX)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
Eli Lilly & Co Common Stock (LLY)

View all positions for Jump Financial

Top funds holding Tourmaline Bio

RA Capital Management
BlackRock
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Jennison Associates
Vanguard Group
Qiming U.S. Ventures Management
QVT Financial
Nantahala Capital Management
Geode Capital Management
Citadel Advisors
Point72 Asset Management
State Street Corporation
Morgan Stanley

View all funds holding Tourmaline Bio